This Quantum Computing Leader Is up 3,310% Since 2023. Is It Too Late to Buy?

D-Wave Quantum reported fiscal 2025 revenue of $24.6 million, up 179% year over year, and first-quarter 2026 bookings hit a record $33.4 million, signaling strong demand despite lumpy revenue. However, losses widened sharply to $355.1 million in 2025 from $143.9 million in 2024, and the stock still trades at about 249x sales. The article frames the company as a high-risk, high-valuation quantum play versus IonQ, with growth largely priced in.

Analysis

The market is treating QBTS less like a software commercialization story and more like a call option on category formation, which explains why bookings momentum matters more than current revenue. The second-order read is that defense-adjacent demand can create a credibility bridge: once quantum is framed as mission-relevant infrastructure, procurement cycles can lengthen into multi-quarter visibility and make capital raises easier to digest. That said, the bar for fundamental re-rating is still extremely high because valuation already discounts a multiyear adoption curve, so incremental good news may support the stock more than it drives a durable rerating.

The real competitive signal is not just QBTS versus IONQ, but whether the market starts rewarding platform breadth over near-term monetization. A dual-platform pitch can attract strategic interest, but it also risks increasing complexity and capex intensity before product-market fit is proven. If integration execution slips, the acquisition becomes a balance-sheet story rather than a growth story, and that is where the downside can accelerate because investors will start underwriting dilution rather than TAM expansion.

Consensus may be underestimating how much of the current enthusiasm is positioning-driven and how little operating proof is needed to keep the stock elevated in the short run. Over the next 1-3 months, the key catalyst is not revenue, but whether bookings convert into repeatable backlog and whether management can avoid signaling larger-than-expected cash burn. Over 6-12 months, the more important question is whether defense and enterprise pilots can expand into contract structures that look like durable demand, or whether the company remains dependent on sporadic headline wins.

Key Decisions for Investors

• Avoid initiating a fresh full-size long in QBTS here; if you want exposure, use a starter position only after a post-rally pullback of 15-20% or on confirmation that bookings convert into backlog over the next 1-2 quarters. Risk/reward is poor at current implied expectations.
• Pair trade: long IONQ / short QBTS for 3-6 months if you believe scale and monetization will continue to win over platform novelty. IONQ has the cleaner revenue base, while QBTS carries more execution and dilution risk.
• For event-driven exposure, buy QBTS call spreads 3-6 months out rather than common stock if you expect another defense-related headline. This caps downside while preserving upside from sentiment spikes, which is the dominant near-term driver.
• If QBTS announces equity financing or larger-than-expected integration costs from the acquisition, consider shorting the stock on the first relief rally. The market is likely to punish any sign that growth is being funded by dilution rather than operating leverage.
• Monitor defense procurement announcements over the next 90 days; if the collaboration turns into a named pilot or funded program, that would justify a tactical long. Without that conversion, the defense narrative remains promotional rather than monetizable.